ISPCiSpecimen Inc.

Nasdaq ispecimen.com


$ 0.24 $ -0.03 (-11.25 %)    

Friday, 10-May-2024 15:59:55 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.2398
$ 0.25
$ 0.00 x 0
$ 0.00 x 0
$ 0.24 - $ 0.25
$ 0.20 - $ 1.88
361,630
na
2.19M
$ 0.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-21-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-22-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ispecimen-q4-earnings-insights
iSpecimen: Q4 Earnings Insights
03/13/2024 21:40:06

 ispecimen-q4-2023-gaap-eps-034-misses-024-estimate-sales-2575m-miss-3041m-estimate

iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.24) b...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

 earnings-outlook-for-ispecimen
Earnings Outlook For iSpecimen
03/12/2024 17:01:07

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION